Clinical trial
A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With…
NCT00072670 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00072670 |
|---|---|
| Title | A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer |
| Official title | Phase 2 Study of Yondelis in Men With Advanced Prostate Carcinoma |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | PharmaMar Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Trabectedin |
| Enrollment | 59 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Nov 11, 2003 |
| Last update posted | Apr 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: